DEFM14A: Horizon Tech Finance to Acquire Monroe Capital in Strategic BDC Merger

Horizon Technology Finance Corporation (HRZN) proposes to acquire Monroe Capital Corporation (MRCC) in a two-step merger, following MRCC's asset sale to affiliate Monroe Capital Income Plus Corporation (MCIP), aiming for enhanced scale and diversification.

Summary

• HRZN and MRCC are proposing a combination of both companies, with HRZN continuing as the surviving entity.
• The transaction involves a two-step process: first, MRCC will sell all its investment assets to MCIP for cash at fair value (Asset Sale), and immediately thereafter, MRCC will merge into HRZN (Merger).
• MRCC stockholders will receive HRZN common stock based on an Exchange Ratio calculated from the net asset values (NAV) per share of MRCC and HRZN as of a mutually agreed Determination Date, no earlier than 48 hours prior to the merger's effective date.
• The HRZN Advisor has agreed to waive $4.0 million of Base Management Fees and/or Incentive Fees, at a rate of $1.0 million per quarter, for four fiscal quarters following the merger's closing.
• HRZN expects to receive approximately $162.4 million in cash proceeds (before HRZN transaction expenses) from the transactions, based on September 30, 2025 NAVs.
• The HRZN Board and MRCC Board, based on recommendations from their respective special committees, unanimously approved the merger and related transactions.
• The merger is intended to qualify as a tax-free reorganization for U.S. federal income tax purposes for MRCC stockholders, except for cash received in lieu of fractional shares.
• HRZN stockholders will vote on the issuance of HRZN common stock for the merger and the election of one Class I director, Thomas J. Allison, from MRCC's board.
• MRCC stockholders will vote on the Asset Sale and the Merger Proposal.

Sentiment

Score: 7

Explanation: The overall sentiment is positive, driven by the unanimous board recommendations and anticipated long-term strategic benefits such as enhanced scale, diversification, NII accretion, and cost savings. While short-term risks like initial NAV dilution and potential dividend adjustments are acknowledged, they are presented within the context of a beneficial strategic move.

Positives

• The combined company is expected to benefit from enhanced scale and diversification, with additional equity capital of approximately $165 million (before HRZN transaction expenses) and a pro forma NAV of approximately $446 million (based on June 30, 2025 financial information).
• The merger is expected to be neutral to Net Investment Income (NII) for the combined company in the first year post-closing and accretive over time, driven by operational savings, portfolio mix optimization, and capital structure improvements.
• The transaction provides incremental capital to execute HRZN's investment strategy and broaden its lending opportunities, potentially at a lower cost than a public or private equity offering.
• The greater scale and diversification could lead to better access to a wider array of debt funding solutions and potential borrowing cost reductions over time.
• The HRZN Advisor will waive $4.0 million in advisory fees over four quarters post-closing, reducing expenses for the combined company.
• Operational synergies are anticipated from the elimination of redundant professional services and other corporate expenses, leading to a reduced annual operating expense as a percentage of net assets.
• The merger is expected to be a tax-free reorganization for U.S. federal income tax purposes for HRZN and MRCC stockholders (except for fractional shares).
• MRCC's investment portfolio will be monetized for cash at fair value through the Asset Sale to MCIP.

Negatives

• MRCC stockholders and HRZN stockholders will experience a reduction in percentage ownership and voting power in the combined company.
• Sales of HRZN Common Stock by former MRCC stockholders after the merger could depress HRZN's market price.
• Management attention may be diverted from normal operations due to the merger process.
• There is a potential for reduced dividend rates for the surviving company in fiscal year 2026 from 2025 levels, as the HRZN Board will monitor NII and may adjust distributions.
• Restrictions on business conduct during the pending transaction could prevent HRZN and MRCC from pursuing certain opportunities.
• Termination fees of $5.4 million (MRCC to HRZN/MCIP) or $11 million (HRZN to MRCC) may be payable under certain termination scenarios, which could discourage alternative proposals.
• HRZN stockholders are not entitled to appraisal rights under Delaware law, and MRCC stockholders are not entitled to appraisal rights under Maryland law for this transaction.
• The potential increase in advisory fees under the HRZN Investment Management Agreement after the Fee Waiver expires is a concern for MRCC stockholders.

Risks

• The merger may not be completed or may be unduly delayed due to failure to obtain required stockholder or regulatory approvals.
• The anticipated benefits of the merger, including estimated cost savings and NII accretion, may not be fully realized or may take longer than expected.
• The merger and/or asset sale may trigger change of control provisions or other restrictions in existing contracts, potentially leading to termination or increased obligations.
• The opinions of financial advisors do not reflect changes in circumstances after their issuance date (August 7, 2025).
• Substantial expenses incurred in pursuing the transactions will not benefit the companies if the merger does not close.
• Termination of the merger or asset purchase agreements could negatively impact MRCC and HRZN, including potential declines in stock price.
• HRZN and MRCC could have indemnification obligations to their officers and directors.
• The merger agreements limit the ability of HRZN and MRCC to pursue alternative transactions.
• HRZN and MRCC will be subject to operational uncertainties and contractual restrictions while the transactions are pending.
• The shares of HRZN Common Stock received by MRCC stockholders will have different rights than their current MRCC shares (e.g., HRZN bylaws do not allow a majority of stockholders to call a special meeting, unlike MRCC).
• The market price of HRZN Common Stock after the merger may be affected by different factors than currently affecting HRZN or MRCC independently.
• HRZN may not replicate its historical performance or the historical success of HRZN or MRCC.
• HRZN must efficiently deploy approximately $162.4 million in cash proceeds within 90 days post-closing, subject to market conditions, and failure to do so could diminish returns.
• Litigation risk associated with mergers of publicly traded companies could divert management time and resources.

Future Outlook

The merger is expected to be neutral to the combined company's Net Investment Income (NII) in the first year post-closing, becoming accretive over time due to operational savings, portfolio mix optimization, and capital structure improvements. HRZN intends to invest the approximately $162.4 million in cash proceeds from the transactions into loans and other assets consistent with its investment strategy within 90 days, subject to market conditions. The HRZN Board will determine future distribution amounts in February 2026, which could be lower than 2025 levels, to maintain a balance between income and distributions over the long-term.

Management Comments

• The HRZN Board, based on the recommendation of a special committee of independent directors, unanimously approved the Merger Agreement and related transactions, and unanimously recommends HRZN stockholders vote FOR the Merger Stock Issuance Proposal and FOR the Director Election Proposal.
• The MRCC Board, based on the recommendation of a special committee of independent directors, unanimously approved the Asset Purchase Agreement, Asset Sale, Merger Agreement, and Merger, and unanimously recommends MRCC stockholders vote FOR the Asset Sale Proposal and FOR the Merger Proposal.
• HRZN Advisor intends to invest the cash proceeds from the transactions in investments consistent with HRZN's investment strategy within 90 days following completion, subject to market conditions, benefiting from a strong investment pipeline and the operational scale of the Monroe platform.

Industry Context

The proposed merger aligns with a broader industry trend where Business Development Companies (BDCs) with smaller market capitalizations tend to trade at a larger discount or smaller premium to net asset value compared to larger BDCs. The combined entity's increased size and scale are expected to improve access to equity capital markets, facilitate better debt financings, and potentially reduce overall borrowing costs, which are key advantages for larger BDCs.

Comparison to Industry Standards

• **Selected Transactions Analysis (Houlihan Lokey for MRCC Special Committee):** Reviewed 12 related-party BDC mergers since September 2019. The implied transaction value as a multiple of NAV per share of the acquired company ranged from 0.90x to 1.14x, with an average of 1.01x and a median of 1.00x. The proposed Merger's implied transaction multiple based on Adjusted June 30 NAVs is 1.00x, falling within this range.
• **Selected Companies Analysis (Houlihan Lokey for MRCC Special Committee):**
• **MRCC Comparables (5 companies):** Price/FY2025E Adjusted EPS ranged from 7.2x to 13.3x (Mean 8.7x, Median 7.7x). Price/MRQ Net Asset Value Per Share ranged from 0.50x to 1.26x (Mean 0.83x, Median 0.76x). LQA Dividend Yield ranged from 7.4% to 20.3% (Mean 15.1%, Median 16.4%).
• **HRZN Comparables (Venture Credit Focused BDCs 4 companies):** Price/FY2025E Adjusted EPS ranged from 5.9x to 10.1x (Mean 7.5x, Median 7.0x). Price/MRQ Net Asset Value Per Share ranged from 0.80x to 1.63x (Mean 1.09x, Median 0.97x). LQA Dividend Yield ranged from 9.7% to 17.4% (Mean 13.5%, Median 13.4%).
• **HRZN Comparables (Other Credit Focused BDCs of similar size 3 companies):** Price/FY2025E Adjusted EPS ranged from 7.2x to 13.3x (Mean 10.3x, Median 10.3x). Price/MRQ Net Asset Value Per Share ranged from 0.73x to 1.26x (Mean 1.01x, Median 1.06x). LQA Dividend Yield ranged from 7.4% to 20.3% (Mean 13.0%, Median 11.4%).
• **Merger Impact Analysis (Oppenheimer for HRZN Special Committee):** The merger is projected to result in an implied accretion (dilution) to HRZN's NAV per share of (0.8%) as of December 31, 2026, 1.8% as of December 31, 2027, and 5.5% as of December 31, 2028. Net investment income per share is projected to be 0.0% accretion (dilution) as of December 31, 2026 and 2027, and 7.8% as of December 31, 2028.
• **Dividend Discount Analysis (Oppenheimer for HRZN Special Committee):** Implied values per share of HRZN Common Stock on a standalone basis ranged from $7.14 to $8.43. On a pro forma basis (giving effect to the Transactions), the implied values ranged from $7.64 to $9.11, suggesting a potential premium post-merger.

Management Changes

Corporate Governance

Legal Proceedings

• Mergers of publicly traded companies are frequently the subject of litigation, and if any litigation arises in connection with the Merger, even if without merit, it could divert management time and resources.

Related Party Transactions

• The Asset Sale involves MRCC selling its investment assets to Monroe Capital Income Plus Corporation (MCIP), an affiliate of MRCC, with both entities managed by Monroe Capital BDC Advisors, LLC (MC Advisors).
• The HRZN Advisor (Horizon Technology Finance Management LLC) became an indirect subsidiary of Monroe Capital in June 2023, making the merger between HRZN and MRCC a related-party transaction.
• The HRZN Advisor has agreed to a $4.0 million fee waiver to HRZN, contingent on the merger, which is a direct financial benefit to the combined entity from a related party.

Stakeholder Impact

• **Shareholders (HRZN & MRCC):** Will experience a reduction in percentage ownership and voting power in the combined company. MRCC stockholders will receive HRZN common stock. Potential for initial dilution to HRZN's NAV per share and possible reduction in dividend rates in the short term, but expected long-term NII accretion.
• **Management/Advisors:** HRZN Advisor will continue as the investment adviser for the combined company. The HRZN Board will be reconstituted to include an independent director from MRCC, and several current HRZN directors are expected to resign. The HRZN Advisor will provide a fee waiver.
• **Customers/Portfolio Companies:** The combined company is expected to have enhanced scale and diversification, potentially leading to greater participation in investments and improved access to debt funding solutions, which could benefit portfolio companies.

Next Steps

• HRZN and MRCC stockholders will hold Special Meetings on March 13, 2026, to vote on the proposed transactions.
• HRZN Advisor intends to invest the approximately $162.4 million in cash proceeds from the transactions within 90 days following completion, subject to market conditions.
• The HRZN Board will determine the next amount of distributions payable to HRZN stockholders in February 2026, taking into account Q4 2025 operating results, spillover income, and the impact of the merger.

Key Dates

Recommendation

The proposed merger between HRZN and MRCC, while strategically sound for long-term growth, scale, and diversification, presents near-term uncertainties. The anticipated initial dilution to HRZN's NAV per share and the potential for reduced dividend rates in fiscal year 2026 could create short-term price volatility. While the $4.0 million fee waiver and expected long-term NII accretion are positive, the immediate impact on shareholder value and the integration risks warrant a cautious 'hold' stance. Investors should monitor the actualization of synergies, capital deployment efficiency, and dividend policy post-merger before making further investment decisions.

Keywords

Merger, Acquisition, Business Development Company, BDC, Asset Sale, SEC Filing, Proxy Statement, Shareholder Vote, NAV, Exchange Ratio, Fee Waiver, Corporate Finance, Investment Management, Technology Finance, Middle Market Lending